A model, globulin-platelet model (GP), was shown to be a more accurate noninvasive fibrosis model than APRI and FIB-4 to diagnose significant fibrosis and cirrhosis in chronic hepatitis B patients with high HBV DNA and mildly elevated ALT levels [29], but it has not been validated. The gene discussed is GPT; the disease is chronic hepatitis B virus infection.